These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33160375)

  • 1. Reaching the unreached: effectiveness and satisfaction with community-directed distribution of sulfadoxine-pyrimethamine for preventing malaria in pregnancy in rural South-East, Nigeria.
    Okedo-Alex IN; Akamike IC; Alo CN; Agu AP; Nzeh CB; Ndukwe CD; Okoro OO; Abateneh DD; Uneke CJ
    Malar J; 2020 Nov; 19(1):394. PubMed ID: 33160375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
    Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
    Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decomposition of socioeconomic inequalities in the uptake of intermittent preventive treatment of malaria in pregnancy in Nigeria: evidence from Demographic Health Survey.
    Okoli CI; Hajizadeh M; Rahman MM; Khanam R
    Malar J; 2021 Jul; 20(1):300. PubMed ID: 34217299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
    Noguchi L; Grenier L; Kabue M; Ugwa E; Oyetunji J; Suhowatsky S; Onguti B; Orji B; Whiting-Collins L; Adetiloye O
    Malar J; 2020 Jan; 19(1):51. PubMed ID: 31996209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment.
    Koita K; Kayentao K; Worrall E; Van Eijk AM; Hill J
    Lancet Glob Health; 2024 Sep; 12(9):e1456-e1469. PubMed ID: 39151981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria.
    Adewole AO; Fawole O; Ajayi I; Yusuf B; Oladimeji A; Waziri E; Nguku P; Ajumobi O
    Pan Afr Med J; 2019; 33():101. PubMed ID: 31489079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.
    Hill J; Dellicour S; Bruce J; Ouma P; Smedley J; Otieno P; Ombock M; Kariuki S; Desai M; Hamel MJ; ter Kuile FO; Webster J
    PLoS One; 2013; 8(6):e64913. PubMed ID: 23798997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery effectiveness of and adherence to intermittent preventive treatment for malaria in pregnancy with dihydroartemisinin-piperaquine with or without targeted information transfer or sulfadoxine-pyrimethamine in western Kenya: a three-armed, pragmatic, open-label, cluster-randomised trial.
    Barsosio HC; Webster J; Omiti F; K'Oloo A; Odero IA; Ojuok MA; Odiwa D; Omondi B; Okello E; Dodd J; Taegtmeyer M; Kuile FOT; Lesosky M; Kariuki S; Hill J
    Lancet Glob Health; 2024 Oct; 12(10):e1660-e1672. PubMed ID: 39304238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.
    Akinleye SO; Falade CO; Ajayi IO
    BMC Pregnancy Childbirth; 2009 Jul; 9():28. PubMed ID: 19589164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of the optimal uptake of sulfadoxine-pyrimethamine doses for intermittent treatment of malaria in pregnancy in urban Nigeria.
    Adeojo OS; Fayehun O
    Sci Rep; 2024 Aug; 14(1):19097. PubMed ID: 39154035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali.
    Diarra SS; Konaté D; Diawara SI; Tall M; Diakité M; Doumbia S
    J Parasitol; 2019 Apr; 105(2):299-302. PubMed ID: 30969162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
    Olliaro PL; Delenne H; Cisse M; Badiane M; Olliaro A; Vaillant M; Brasseur P
    Malar J; 2008 Nov; 7():234. PubMed ID: 18992140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.